මධ්යස්ථානය සම්බන්ධ කර ගන්නේ කෙසේද
HCP මධ්යස්ථානය
Rigshospitalet හි ඓතිහාසික පසුබිම ඩෙන්මාර්කයේ පළමු සැබෑ රෝහල වන "The Royal Frederiks Hospital" දක්වා දිව යයි, එය දුප්පත් කෝපන්හේගන් වැසියන්ට අනුයුක්තව රැකවරණය සහ ප්‍රතිකාර කිරීම සඳහා පිහිටුවන ලදී. රෝහල 1757 දී විවෘත කරන ලද අතර බ්‍රෙඩ්ගේඩ් හි පිහිටා ඇති අතර එහිදී ඔබට අද කුන්ස්ටින්ඩුස්ට්‍රිමුසීට් සොයාගත හැකිය. 1910 දී, රෝහල ප්‍රාන්තයේ කොටසක් බවට පත් වූ අතර බ්ලෙග්ඩම්ස්වෙජ් හි වර්තමාන ස්ථානයට මාරු විය. අනාගතයේදී එය රාජධානියේ සියලුම පුරවැසියන්ට ලබා ගත යුතු බැවින් රෝහල එහි නම Rigshospitalet ලෙසද වෙනස් කළේය. නවීන Rigshospital, එහි උස අළු ගොඩනැගිලි, 1960 ගණන්වල සිට ආරම්භ වන අතර අද එය අගනුවර කලාපයේ කොටසකි.
පින්තූරය: Ole Morten Nygård
අමතන්න
Rigshospitalet, Copenhagen, Denmark
කණ්ඩායම
Dr Steffen HAMANN
ඩෙන්මාර්කය
Pr Michael LARSEN
ඩෙන්මාර්කය
Line Kessel
ඩෙන්මාර්කය
සායනික පරීක්ෂණ
A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.
This is a single-arm open label interventional safety trial with RP patients, who receive weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary outcome measure is safety, indicated by the frequency and severity of adverse events.
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
Safety and Efficacy of Emixustat in Stargardt Disease.
Efficacy and safety of QLT091001 in subjects with Inherited Retinal Disease (IRD) caused by gene mutations.
A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT.
Clinical and Genetic Examination of Usher Syndrome Patients’ Cohort in Europe.
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Advanced Characterization of Autosomal Dominant Optic Atrophy.
Transcorneal Electrical Stimulation - Multicenter Safety Study.
Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen
Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Factors: New Perspectives
A Head-to-head Comparison of Ultrasound Versus Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
Global Patient Registry of Inherited Retinal Disease